RXFP2 Small Molecule Agonists: Potential Therapeutics for Osteoporosis
María Esteban-López(Dr. Herbert & Nicole Wertheim Family Foundation), Alexander I. Agoulnik(Florida International University), Elena M. Kaftanovskaya(Florida International University), Noel Southall(National Center for Advancing Translational Sciences), Irina U. Agoulnik(University of South Florida), Wenjuan Ye(National Institutes of Health), Xin Hu(National Center for Advancing Translational Sciences), Roy Morello(University of Arkansas for Medical Sciences), Elena Barnaeva(National Center for Advancing Translational Sciences), Kenneth J. Wilson(National Institutes of Health), Mark J. Henderson(National Center for Advancing Translational Sciences), David D. Kim(Chicago Department of Public Health), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Courtney Myhr(Florida International University), Juan Marugan(National Center for Advancing Translational Sciences)
Cited by 0
Related Papers
The Genome of <i>M. acetivorans</i> Reveals Extensive Metabolic and Physiological Diversity
|Genome Research|2002|634
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse
|Nature Genetics|2000|351
Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene
|American Journal Of Pathology|2001|279